婴儿膀胱输尿管反流的内镜治疗:可行性与适应证探讨
回顾性分析463个输尿管单位(296例患儿),比较1岁以下婴儿组与年长儿童组内镜注射治疗膀胱输尿管反流的效果。婴儿组高级别反流和反流性肾病比例更高,早期失败率和复发率均显著高于年长组,但婴儿组无并发症,有效率仍超过80%。作者认为该治疗在1岁以下患儿中可行,但适应证需综合选择。
要点
- 婴儿组高级别反流和反流性肾病比例显著高于年长儿童组。
- 婴儿组早期失败率和复发率均显著高于年长儿童组,但无并发症。
- 婴儿组内镜治疗有效率仍超过80%,作者认为该治疗可行。
核心结论
- 内镜治疗膀胱输尿管反流在1岁以下患儿中可行,有效率低于年长后治疗但本系列仍超过80%。
- 未报告与操作本身或全身麻醉相关的并发症。
- 作者认为适应证选择需考虑反流自行消退可能性低、存在突破性感染及家长意愿。
研究设计与样本
- 回顾性分析本机构因膀胱输尿管反流接受内镜注射填充物治疗的患儿,比较婴儿期治疗与年长后治疗的患者。
- 共纳入463个输尿管单位(296例儿童),其中47例为1岁以下婴儿(INF组),其余416例为年长儿童(CHL组)。
主要发现
- 婴儿组高级别反流比例和反流性肾病存在比例均显著高于年长儿童组。
- 婴儿组早期失败率和复发率均显著高于年长儿童组。
- 婴儿组未观察到并发症。
临床怎么用
- 作者认为内镜治疗膀胱输尿管反流在1岁以下患儿中可行。
- 作者认为适应证选择需综合反流自行消退可能性低、存在突破性感染及家长意愿等因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the outcomes of endoscopic treatment of vesicoureteral reflux (VUR) performed on infants, and to discuss the possible role of this approach in selected cases. MATERIAL AND METHODS: A retrospective analysis was conducted on the patients who underwent endoscopic injection of a bulking substance for VUR in our institution, and a comparison was made with patients treated during infancy and those treated later in life. RESULTS: A total of 463 ureteral units were included (296 children), of whom 47 were patients less than 1 year of age (infants, INF group); the remaining 416 were included in a second group (children, CHL). In this study, the percentage of high-grade VUR and presence of reflux nephropathy were significantly higher in younger patients. Both early failure and recurrence rate were significantly higher in the INF group when compared with the CHL group. No complications were observed in the INF group. CONCLUSION: Endoscopic treatment of VUR is feasible in patients less than 1 year of age. The effectiveness is lower than when patients are treated at a later age but was still over 80% in our series. There were no complications reported related to the procedure itself or to the general anesthesia. Once it is known that endoscopic treatment of VUR can be performed, controversy arises about the indication of treating patients with VUR. Careful selection of VUR cases that are less likely to spontaneously resolve, presence of breakthrough infections, and parental preference, all play a role in the decision-making process.
引用
- Fuentes S, Gómez-Fraile A, Carrillo-Arroyo I, et al. Endoscopic Treatment of Vesicoureteral Reflux in Infants. Can We Do It and Should We Do It? Urology. 2017. PMID: 28818534. doi:10.1016/j.urology.2017.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。